全体要約
吸入麻酔薬市場は、2022年の世界の売上高を基に、2023年から2029年までの予測を地域別および市場セクター別に分析しています。アメリカ、中国、ヨーロッパの市場はそれぞれ成長が見込まれ、主要企業にはLinde Healthcare、Air Products、Pfizerなどが含まれます。2022年には、上位2社が市場の約%を占めました。
このレポートは、吸入麻酔薬の製品タイプ、アプリケーション、主要メーカー、地域別の市場シェアと成長機会を包括的に示しています。市場は揮発性麻酔薬、亜酸化窒素、ハロタンなどに分類され、病院やクリニックでの使用が主なアプリケーションです。
関連する質問
2023年から2029年までの予測期間で、吸入麻酔薬市場の成長率は%のCAGRです。
リンドヘルスケア, エアプロダクツ, 太陽日本酸素, メッサーグループ, SOLグループ, ファイザー, ノルコ, ピラマルグループ, ハロカーボン, Dideuグループ, Innopharmchem, Aesica(コンソートメディカルグループ), Rewine製薬, アボットラボラトリーズ, 丸石製薬, コリンズ, マイラン製薬, バクスター, BOCヘルスケア, ヒクマ, インドファインケミカルカンパニー, メディコンライフサイエンシズ, 山東キーユアン製薬, ルナン製薬グループ, 江蘇恒瑞医薬。
製品セグメンテーションの重要なトレンド, 主要企業の戦略的形成, 地理的フットプリントの拡大
概要
LPI (LP Information)の最新の調査報告書「吸入麻酔業界の予測」では、過去の売上を調査し、2022年の世界の吸入麻酔の総売上をレビューしています。また、2023年から2029年にかけての地域別および市場セクター別の予測される吸入麻酔の売上に関する包括的な分析を提供。地域、市場セクターおよびサブセクターごとに分けられた吸入麻酔の売上に基づいて、この報告書は世界の吸入麻酔業界の詳細な分析をUSドル百万単位で提供。
このインサイトレポートは、世界の吸入麻酔薬の状況に関する包括的な分析を提供し、製品のセグメンテーション、企業の形成、収益、市場シェア、最新の動向、M&A活動に関連する重要なトレンドを強調しています。また、このレポートでは、吸入麻酔薬ポートフォリオと能力、市場参入戦略、市場ポジション、地理的なフットプリントに焦点を当てながら、主要なグローバル企業の戦略を分析し、加速する世界の吸入麻酔薬市場におけるこれらの企業のユニークな立場をよりよく理解できるようにしています。
このインサイトレポートは、吸入麻酔剤の世界的な展望を形成する主要な市場トレンド、ドライバー、および影響要因を評価し、タイプ、用途、地理、そして市場規模ごとに予測を分解して、新たな機会の浮上するポケットをハイライトします。何百ものボトムアップの定性的および定量的市場インプットに基づいた透明な方法論により、この調査予測は、吸入麻酔剤の現在の状態と将来の動向について、非常に詳細な見解を提供します。
世界の吸入麻酔市場の規模は、2022年のXX米ドルから2029年のXX米ドルに成長する見込みです。また、2023年から2029年にかけてCAGRがXX%で成長すると予想されています。
アメリカの吸入麻酔薬市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると予測されています。2023年から2029年の間にCAGRはXX%です。
中国の吸入麻酔薬市場は、2022年のXX米ドルから2029年にはXX米ドルに増加すると推定されており、2023年から2029年までの年平均成長率（CAGR）はXX%です。
ヨーロッパの吸入麻酔薬市場は、2022年のXX米ドルから2029年にはXX米ドルに増加すると推定されており、2023年から2029年の間にXX%のCAGRです。
グローバルな主要吸入麻酔薬プレイヤーは、リンデヘルスケア、エアプロダクツ、太陽日本酸素、メッサーグループ、SOLグループ、ファイザー、ノルコ、ピラマルグループ、ハローカーボンなどです。収益の観点から、2022年には世界の最大手2社がほぼXX%のシェアを占めました。
この報告書は、製品タイプ、アプリケーション、主要メーカー、主要地域および国別の吸入麻酔市場の包括的な概要、市場シェア、および成長機会を示しています。
市場セグメンテーション：
タイプ別セグメンテーション
揮発性麻酔薬
一酸化二窒素
ハロタン
その他
用途別セグメンテーション
病院
クリニック
その他
このレポートでは、市場を地域別に分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、一次専門家からの意見収集や、企業のカバー範囲、製品ポートフォリオ、市場浸透度を分析した結果に基づいて選定されました。
リンデヘルスケア
エア・プロダクツ
太陽日本酸素
メッサーグループ
ソルグループ
ファイザー
ノルコ
ピラマルグループ
ハローカーボン
ディデュグループ
イノファームケム
エーシカ（コンソート・メディカル・グループ）
リワイン製薬
アボットラボラトリーズ
丸石製薬
コリンズ
マイラン製薬
バクスター
BOCヘルスケア
ヒクマ
インドファインケミカルカンパニー
メディコンライフサイエンス
山東科源薬業
ルナン製薬グループ
江蘇恒瑞医薬
本報告書での主要な質問
グローバル吸入麻酔市場の10年見通しは何ですか？
全世界及び地域別で吸入麻酔薬市場の成長を促進している要因は何ですか？
市場および地域ごとに最も急速に成長する準備が整っている技術はどれですか？
吸入麻酔市場の機会は、エンド市場の規模によってどのように異なりますか？
吸入麻酔薬の種類、適用方法はどのようですか？
COVID-19とロシア・ウクライナ戦争の影響は何ですか？
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの吸入麻酔薬、年間売上、2018年～2029年
2.1.2 吸入麻酔薬の世界市場の現状分析・将来予測、地理別、2018年、2022年および2029年
2.1.3 吸入麻酔薬の世界市場の現状分析・将来予測、国・地域別、2018年、2022年および2029年
2.2 吸入麻酔薬セグメント、タイプ別
2.2.1 揮発性麻酔薬
2.2.2 亜酸化窒素
2.2.3 ハロタン
2.2.4 その他
2.3 吸入麻酔薬の売上、タイプ別
2.3.1 グローバルにおける吸入麻酔薬の売上・市場シェア、タイプ別（2018年～2023年）
2.3.2 吸入麻酔薬のグローバルレベニュー・市場シェア、タイプ別（2018～2023年）
2.3.3 グローバルの吸入麻酔薬、販売価格（タイプ別）（2018年～2023年）
2.4 吸入麻酔薬セグメント、用途別
2.4.1 病院
2.4.2 クリニック
2.4.3 その他
2.5 吸入麻酔薬の売上、用途別
2.5.1 グローバルの吸入麻酔薬、収益・市場シェア（用途別）（2018年～2023年）
2.5.2 吸入麻酔薬のグローバルレベニュー・市場シェア、用途別（2018～2023年）
2.5.3 グローバルの吸入麻酔薬、販売価格（用途別）（2018年～2023年）
3 グローバルにおける吸入麻酔薬、企業別
3.1 グローバルにおける吸入麻酔薬市場のブレークダウンデータ、企業別
3.1.1 グローバルにおける吸入麻酔薬の年間売上、企業別（2018年～2023年）
3.1.2 グローバルにおける吸入麻酔薬の売上・市場シェア、企業別（2018年～2023年）
3.2 グローバルにおける吸入麻酔薬の年間収益、企業別（2018年～2023年）
3.2.1 グローバルにおける吸入麻酔薬市場の収益規模、企業別（2018年～2023年）
3.2.2 グローバルにおける吸入麻酔薬市場の収益シェア、企業別（2018年～2023年）
3.3 グローバルにおける吸入麻酔薬の販売価格、企業別
3.4 吸入麻酔薬の主要メーカー、生産地域分布、販売地域、製品タイプ
3.4.1 吸入麻酔薬の主要メーカー、製品と拠点の分布
3.4.2 プレイヤーが提供している吸入麻酔薬製品
3.5 市場集中度分析
3.5.1 競合情勢分析
3.5.2 集中度レシオ（CR3、CR5、CR10）（2018年～2023年）
3.6 新製品・潜在的参入
3.7 M&A、拡大
4 吸入麻酔薬の世界市場過去推移レビュー、地理別
4.1 吸入麻酔薬の世界市場規模の過去推移、地理別（2018年～2023年）
4.1.1 グローバルにおける吸入麻酔薬の年間売上、地理別（2018年～2023年）
4.1.2 グローバルにおける吸入麻酔薬の年間収益、地理別（2018年～2023年）
4.2 吸入麻酔薬の世界市場規模の過去推移、国・地域別（2018年～2023年）
4.2.1 グローバルにおける吸入麻酔薬の年間売上、国・地域別（2018年～2023年）
4.2.2 グローバルにおける吸入麻酔薬の年間収益、国・地域別（2018年～2023年）
4.3 アメリカズにおける吸入麻酔薬の売上成長
4.4 APACにおける吸入麻酔薬の売上成長
4.5 ヨーロッパにおける吸入麻酔薬の売上成長
4.6 中東・アフリカにおける吸入麻酔薬の売上成長
5 アメリカズ
5.1 アメリカズにおける吸入麻酔薬の売上、国別
5.1.1 アメリカズにおける吸入麻酔薬の売上規模、国別（2018年～2023年）
5.1.2 アメリカズにおける吸入麻酔薬市場の収益規模、国別（2018年～2023年）
5.2 アメリカズにおける吸入麻酔薬の売上、タイプ別
5.3 アメリカズにおける吸入麻酔薬の売上、用途別
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける吸入麻酔薬の売上、地域別
6.1.1 APACにおける吸入麻酔薬の売上規模、地域別（2018年～2023年）
6.1.2 APACにおける吸入麻酔薬市場の収益規模、地域別（2018年～2023年）
6.2 APACにおける吸入麻酔薬の売上、タイプ別
6.3 APACにおける吸入麻酔薬の売上、用途別
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
6.10 中国の台湾
7 ヨーロッパ
7.1 ヨーロッパにおける吸入麻酔薬、国別
7.1.1 ヨーロッパにおける吸入麻酔薬の売上規模、国別（2018年～2023年）
7.1.2 ヨーロッパにおける吸入麻酔薬市場の収益規模、国別（2018年～2023年）
7.2 ヨーロッパにおける吸入麻酔薬の売上、タイプ別
7.3 ヨーロッパにおける吸入麻酔薬の売上、用途別
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカにおける吸入麻酔薬、国別
8.1.1 中東・アフリカにおける吸入麻酔薬の売上規模、国別（2018年～2023年）
8.1.2 中東・アフリカにおける吸入麻酔薬市場の収益規模、国別（2018年～2023年）
8.2 中東・アフリカにおける吸入麻酔薬の売上、タイプ別
8.3 中東・アフリカにおける吸入麻酔薬の売上、用途別
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 製造コスト構造分析
10.1 原料・サプライヤー
10.2 吸入麻酔薬の製造コスト構造分析
10.3 吸入麻酔薬の製造プロセス分析
10.4 吸入麻酔薬のインダストリーチェーン構造
11 マーケティング・流通・顧客
11.1 販売チャネル
11.1.1 直接チャネル
11.1.2 間接チャネル
11.2 吸入麻酔薬の流通業者
11.3 吸入麻酔薬の顧客
12 吸入麻酔薬の世界市場予測レビュー、地理別
12.1 グローバルにおける吸入麻酔薬の市場規模予測、地域別
12.1.1 グローバルの吸入麻酔薬、市場予測（地域別）（2024年～2029年）
12.1.2 グローバルの吸入麻酔薬、年間収益予測（地域別）（2024年～2029年）
12.2 アメリカズにおける予測、国別
12.3 APACにおける予測、地域別
12.4 ヨーロッパにおける予測、国別
12.5 中東・アフリカにおける予測、国別
12.6 グローバルにおける吸入麻酔薬の市場予測、タイプ別
12.7 グローバルにおける吸入麻酔薬の市場予測、用途別
13 キープレイヤー分析
13.1 Linde Healthcare
13.1.1 Linde Healthcare：企業情報
13.1.2 Linde Healthcare：吸入麻酔薬製品ポートフォリオと特徴
13.1.3 Linde Healthcare：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.1.4 Linde Healthcare：主要事業概要
13.1.5 Linde Healthcare：直近の展開
13.2 Air Products
13.2.1 Air Products：企業情報
13.2.2 Air Products：吸入麻酔薬製品ポートフォリオと特徴
13.2.3 Air Products：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.2.4 Air Products：主要事業概要
13.2.5 Air Products：直近の展開
13.3 Taiyo Nippon Sanso
13.3.1 Taiyo Nippon Sanso：企業情報
13.3.2 Taiyo Nippon Sanso：吸入麻酔薬製品ポートフォリオと特徴
13.3.3 Taiyo Nippon Sanso：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.3.4 Taiyo Nippon Sanso：主要事業概要
13.3.5 Taiyo Nippon Sanso：直近の展開
13.4 Messer Group
13.4.1 Messer Group：企業情報
13.4.2 Messer Group：吸入麻酔薬製品ポートフォリオと特徴
13.4.3 Messer Group：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.4.4 Messer Group：主要事業概要
13.4.5 Messer Group：直近の展開
13.5 SOL Group
13.5.1 SOL Group：企業情報
13.5.2 SOL Group：吸入麻酔薬製品ポートフォリオと特徴
13.5.3 SOL Group：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.5.4 SOL Group：主要事業概要
13.5.5 SOL Group：直近の展開
13.6 Pfizer
13.6.1 Pfizer：企業情報
13.6.2 Pfizer：吸入麻酔薬製品ポートフォリオと特徴
13.6.3 Pfizer：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.6.4 Pfizer：主要事業概要
13.6.5 Pfizer：直近の展開
13.7 Norco
13.7.1 Norco：企業情報
13.7.2 Norco：吸入麻酔薬製品ポートフォリオと特徴
13.7.3 Norco：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.7.4 Norco：主要事業概要
13.7.5 Norco：直近の展開
13.8 Piramal Group
13.8.1 Piramal Group：企業情報
13.8.2 Piramal Group：吸入麻酔薬製品ポートフォリオと特徴
13.8.3 Piramal Group：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.8.4 Piramal Group：主要事業概要
13.8.5 Piramal Group：直近の展開
13.9 Halocarbon
13.9.1 Halocarbon：企業情報
13.9.2 Halocarbon：吸入麻酔薬製品ポートフォリオと特徴
13.9.3 Halocarbon：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.9.4 Halocarbon：主要事業概要
13.9.5 Halocarbon：直近の展開
13.10 Dideu Group
13.10.1 Dideu Group：企業情報
13.10.2 Dideu Group：吸入麻酔薬製品ポートフォリオと特徴
13.10.3 Dideu Group：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.10.4 Dideu Group：主要事業概要
13.10.5 Dideu Group：直近の展開
13.11 Innopharmchem
13.11.1 Innopharmchem：企業情報
13.11.2 Innopharmchem：吸入麻酔薬製品ポートフォリオと特徴
13.11.3 Innopharmchem：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.11.4 Innopharmchem：主要事業概要
13.11.5 Innopharmchem：直近の展開
13.12 Aesica\(Consort Medical Group\)
13.12.1 Aesica\(Consort Medical Group\)：企業情報
13.12.2 Aesica\(Consort Medical Group\)：吸入麻酔薬製品ポートフォリオと特徴
13.12.3 Aesica\(Consort Medical Group\)：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.12.4 Aesica\(Consort Medical Group\)：主要事業概要
13.12.5 Aesica\(Consort Medical Group\)：直近の展開
13.13 Rewine Pharmaceutical
13.13.1 Rewine Pharmaceutical：企業情報
13.13.2 Rewine Pharmaceutical：吸入麻酔薬製品ポートフォリオと特徴
13.13.3 Rewine Pharmaceutical：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.13.4 Rewine Pharmaceutical：主要事業概要
13.13.5 Rewine Pharmaceutical：直近の展開
13.14 Abbott Laboratories
13.14.1 Abbott Laboratories：企業情報
13.14.2 Abbott Laboratories：吸入麻酔薬製品ポートフォリオと特徴
13.14.3 Abbott Laboratories：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.14.4 Abbott Laboratories：主要事業概要
13.14.5 Abbott Laboratories：直近の展開
13.15 Maruishi Pharmaceutical
13.15.1 Maruishi Pharmaceutical：企業情報
13.15.2 Maruishi Pharmaceutical：吸入麻酔薬製品ポートフォリオと特徴
13.15.3 Maruishi Pharmaceutical：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.15.4 Maruishi Pharmaceutical：主要事業概要
13.15.5 Maruishi Pharmaceutical：直近の展開
13.16 Collins
13.16.1 Collins：企業情報
13.16.2 Collins：吸入麻酔薬製品ポートフォリオと特徴
13.16.3 Collins：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.16.4 Collins：主要事業概要
13.16.5 Collins：直近の展開
13.17 Mylan Seiyaku
13.17.1 Mylan Seiyaku：企業情報
13.17.2 Mylan Seiyaku：吸入麻酔薬製品ポートフォリオと特徴
13.17.3 Mylan Seiyaku：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.17.4 Mylan Seiyaku：主要事業概要
13.17.5 Mylan Seiyaku：直近の展開
13.18 Baxter
13.18.1 Baxter：企業情報
13.18.2 Baxter：吸入麻酔薬製品ポートフォリオと特徴
13.18.3 Baxter：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.18.4 Baxter：主要事業概要
13.18.5 Baxter：直近の展開
13.19 BOC Healthcare
13.19.1 BOC Healthcare：企業情報
13.19.2 BOC Healthcare：吸入麻酔薬製品ポートフォリオと特徴
13.19.3 BOC Healthcare：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.19.4 BOC Healthcare：主要事業概要
13.19.5 BOC Healthcare：直近の展開
13.20 Hikma
13.20.1 Hikma：企業情報
13.20.2 Hikma：吸入麻酔薬製品ポートフォリオと特徴
13.20.3 Hikma：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.20.4 Hikma：主要事業概要
13.20.5 Hikma：直近の展開
13.21 Indofine Chemical Company
13.21.1 Indofine Chemical Company：企業情報
13.21.2 Indofine Chemical Company：吸入麻酔薬製品ポートフォリオと特徴
13.21.3 Indofine Chemical Company：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.21.4 Indofine Chemical Company：主要事業概要
13.21.5 Indofine Chemical Company：直近の展開
13.22 Medicon Lifesciences
13.22.1 Medicon Lifesciences：企業情報
13.22.2 Medicon Lifesciences：吸入麻酔薬製品ポートフォリオと特徴
13.22.3 Medicon Lifesciences：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.22.4 Medicon Lifesciences：主要事業概要
13.22.5 Medicon Lifesciences：直近の展開
13.23 Shandong Keyuan Pharmaceutical
13.23.1 Shandong Keyuan Pharmaceutical：企業情報
13.23.2 Shandong Keyuan Pharmaceutical：吸入麻酔薬製品ポートフォリオと特徴
13.23.3 Shandong Keyuan Pharmaceutical：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.23.4 Shandong Keyuan Pharmaceutical：主要事業概要
13.23.5 Shandong Keyuan Pharmaceutical：直近の展開
13.24 Lunan Pharmaceutical Group
13.24.1 Lunan Pharmaceutical Group：企業情報
13.24.2 Lunan Pharmaceutical Group：吸入麻酔薬製品ポートフォリオと特徴
13.24.3 Lunan Pharmaceutical Group：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.24.4 Lunan Pharmaceutical Group：主要事業概要
13.24.5 Lunan Pharmaceutical Group：直近の展開
13.25 Jiangsu Hengrui Medicine
13.25.1 Jiangsu Hengrui Medicine：企業情報
13.25.2 Jiangsu Hengrui Medicine：吸入麻酔薬製品ポートフォリオと特徴
13.25.3 Jiangsu Hengrui Medicine：吸入麻酔薬売上・収益・価格およびグロスマージン（2018年～2023年）
13.25.4 Jiangsu Hengrui Medicine：主要事業概要
13.25.5 Jiangsu Hengrui Medicine：直近の展開
14 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
LPI (LP Information)' newest research report, the “Inhalational Anesthetic Industry Forecast” looks at past sales and reviews total world Inhalational Anesthetic sales in 2022, providing a comprehensive analysis by region and market sector of projected Inhalational Anesthetic sales for 2023 through 2029. With Inhalational Anesthetic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhalational Anesthetic industry.
This Insight Report provides a comprehensive analysis of the global Inhalational Anesthetic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhalational Anesthetic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Inhalational Anesthetic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhalational Anesthetic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhalational Anesthetic.
The global Inhalational Anesthetic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Inhalational Anesthetic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Inhalational Anesthetic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Inhalational Anesthetic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Inhalational Anesthetic players cover Linde Healthcare, Air Products, Taiyo Nippon Sanso, Messer Group, SOL Group, Pfizer, Norco, Piramal Group and Halocarbon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalational Anesthetic market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Volatile Anesthetic Agents
Nitrous Oxide
Halothane
Others
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Linde Healthcare
Air Products
Taiyo Nippon Sanso
Messer Group
SOL Group
Pfizer
Norco
Piramal Group
Halocarbon
Dideu Group
Innopharmchem
Aesica(Consort Medical Group)
Rewine Pharmaceutical
Abbott Laboratories
Maruishi Pharmaceutical
Collins
Mylan Seiyaku
Baxter
BOC Healthcare
Hikma
Indofine Chemical Company
Medicon Lifesciences
Shandong Keyuan Pharmaceutical
Lunan Pharmaceutical Group
Jiangsu Hengrui Medicine
Key Questions Addressed in this Report
What is the 10-year outlook for the global Inhalational Anesthetic market?
What factors are driving Inhalational Anesthetic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inhalational Anesthetic market opportunities vary by end market size?
How does Inhalational Anesthetic break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Inhalational Anesthetic Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Inhalational Anesthetic by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Inhalational Anesthetic by Country/Region, 2018, 2022 & 2029
2.2 Inhalational Anesthetic Segment by Type
2.2.1 Volatile Anesthetic Agents
2.2.2 Nitrous Oxide
2.2.3 Halothane
2.2.4 Others
2.3 Inhalational Anesthetic Sales by Type
2.3.1 Global Inhalational Anesthetic Sales Market Share by Type (2018-2023)
2.3.2 Global Inhalational Anesthetic Revenue and Market Share by Type (2018-2023)
2.3.3 Global Inhalational Anesthetic Sale Price by Type (2018-2023)
2.4 Inhalational Anesthetic Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Inhalational Anesthetic Sales by Application
2.5.1 Global Inhalational Anesthetic Sale Market Share by Application (2018-2023)
2.5.2 Global Inhalational Anesthetic Revenue and Market Share by Application (2018-2023)
2.5.3 Global Inhalational Anesthetic Sale Price by Application (2018-2023)
3 Global Inhalational Anesthetic by Company
3.1 Global Inhalational Anesthetic Breakdown Data by Company
3.1.1 Global Inhalational Anesthetic Annual Sales by Company (2018-2023)
3.1.2 Global Inhalational Anesthetic Sales Market Share by Company (2018-2023)
3.2 Global Inhalational Anesthetic Annual Revenue by Company (2018-2023)
3.2.1 Global Inhalational Anesthetic Revenue by Company (2018-2023)
3.2.2 Global Inhalational Anesthetic Revenue Market Share by Company (2018-2023)
3.3 Global Inhalational Anesthetic Sale Price by Company
3.4 Key Manufacturers Inhalational Anesthetic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhalational Anesthetic Product Location Distribution
3.4.2 Players Inhalational Anesthetic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Inhalational Anesthetic by Geographic Region
4.1 World Historic Inhalational Anesthetic Market Size by Geographic Region (2018-2023)
4.1.1 Global Inhalational Anesthetic Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Inhalational Anesthetic Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Inhalational Anesthetic Market Size by Country/Region (2018-2023)
4.2.1 Global Inhalational Anesthetic Annual Sales by Country/Region (2018-2023)
4.2.2 Global Inhalational Anesthetic Annual Revenue by Country/Region (2018-2023)
4.3 Americas Inhalational Anesthetic Sales Growth
4.4 APAC Inhalational Anesthetic Sales Growth
4.5 Europe Inhalational Anesthetic Sales Growth
4.6 Middle East & Africa Inhalational Anesthetic Sales Growth
5 Americas
5.1 Americas Inhalational Anesthetic Sales by Country
5.1.1 Americas Inhalational Anesthetic Sales by Country (2018-2023)
5.1.2 Americas Inhalational Anesthetic Revenue by Country (2018-2023)
5.2 Americas Inhalational Anesthetic Sales by Type
5.3 Americas Inhalational Anesthetic Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhalational Anesthetic Sales by Region
6.1.1 APAC Inhalational Anesthetic Sales by Region (2018-2023)
6.1.2 APAC Inhalational Anesthetic Revenue by Region (2018-2023)
6.2 APAC Inhalational Anesthetic Sales by Type
6.3 APAC Inhalational Anesthetic Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Inhalational Anesthetic by Country
7.1.1 Europe Inhalational Anesthetic Sales by Country (2018-2023)
7.1.2 Europe Inhalational Anesthetic Revenue by Country (2018-2023)
7.2 Europe Inhalational Anesthetic Sales by Type
7.3 Europe Inhalational Anesthetic Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Inhalational Anesthetic by Country
8.1.1 Middle East & Africa Inhalational Anesthetic Sales by Country (2018-2023)
8.1.2 Middle East & Africa Inhalational Anesthetic Revenue by Country (2018-2023)
8.2 Middle East & Africa Inhalational Anesthetic Sales by Type
8.3 Middle East & Africa Inhalational Anesthetic Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhalational Anesthetic
10.3 Manufacturing Process Analysis of Inhalational Anesthetic
10.4 Industry Chain Structure of Inhalational Anesthetic
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhalational Anesthetic Distributors
11.3 Inhalational Anesthetic Customer
12 World Forecast Review for Inhalational Anesthetic by Geographic Region
12.1 Global Inhalational Anesthetic Market Size Forecast by Region
12.1.1 Global Inhalational Anesthetic Forecast by Region (2024-2029)
12.1.2 Global Inhalational Anesthetic Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Inhalational Anesthetic Forecast by Type
12.7 Global Inhalational Anesthetic Forecast by Application
13 Key Players Analysis
13.1 Linde Healthcare
13.1.1 Linde Healthcare Company Information
13.1.2 Linde Healthcare Inhalational Anesthetic Product Portfolios and Specifications
13.1.3 Linde Healthcare Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Linde Healthcare Main Business Overview
13.1.5 Linde Healthcare Latest Developments
13.2 Air Products
13.2.1 Air Products Company Information
13.2.2 Air Products Inhalational Anesthetic Product Portfolios and Specifications
13.2.3 Air Products Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Air Products Main Business Overview
13.2.5 Air Products Latest Developments
13.3 Taiyo Nippon Sanso
13.3.1 Taiyo Nippon Sanso Company Information
13.3.2 Taiyo Nippon Sanso Inhalational Anesthetic Product Portfolios and Specifications
13.3.3 Taiyo Nippon Sanso Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Taiyo Nippon Sanso Main Business Overview
13.3.5 Taiyo Nippon Sanso Latest Developments
13.4 Messer Group
13.4.1 Messer Group Company Information
13.4.2 Messer Group Inhalational Anesthetic Product Portfolios and Specifications
13.4.3 Messer Group Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Messer Group Main Business Overview
13.4.5 Messer Group Latest Developments
13.5 SOL Group
13.5.1 SOL Group Company Information
13.5.2 SOL Group Inhalational Anesthetic Product Portfolios and Specifications
13.5.3 SOL Group Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 SOL Group Main Business Overview
13.5.5 SOL Group Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Inhalational Anesthetic Product Portfolios and Specifications
13.6.3 Pfizer Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Norco
13.7.1 Norco Company Information
13.7.2 Norco Inhalational Anesthetic Product Portfolios and Specifications
13.7.3 Norco Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Norco Main Business Overview
13.7.5 Norco Latest Developments
13.8 Piramal Group
13.8.1 Piramal Group Company Information
13.8.2 Piramal Group Inhalational Anesthetic Product Portfolios and Specifications
13.8.3 Piramal Group Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Piramal Group Main Business Overview
13.8.5 Piramal Group Latest Developments
13.9 Halocarbon
13.9.1 Halocarbon Company Information
13.9.2 Halocarbon Inhalational Anesthetic Product Portfolios and Specifications
13.9.3 Halocarbon Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Halocarbon Main Business Overview
13.9.5 Halocarbon Latest Developments
13.10 Dideu Group
13.10.1 Dideu Group Company Information
13.10.2 Dideu Group Inhalational Anesthetic Product Portfolios and Specifications
13.10.3 Dideu Group Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Dideu Group Main Business Overview
13.10.5 Dideu Group Latest Developments
13.11 Innopharmchem
13.11.1 Innopharmchem Company Information
13.11.2 Innopharmchem Inhalational Anesthetic Product Portfolios and Specifications
13.11.3 Innopharmchem Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Innopharmchem Main Business Overview
13.11.5 Innopharmchem Latest Developments
13.12 Aesica(Consort Medical Group)
13.12.1 Aesica(Consort Medical Group) Company Information
13.12.2 Aesica(Consort Medical Group) Inhalational Anesthetic Product Portfolios and Specifications
13.12.3 Aesica(Consort Medical Group) Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Aesica(Consort Medical Group) Main Business Overview
13.12.5 Aesica(Consort Medical Group) Latest Developments
13.13 Rewine Pharmaceutical
13.13.1 Rewine Pharmaceutical Company Information
13.13.2 Rewine Pharmaceutical Inhalational Anesthetic Product Portfolios and Specifications
13.13.3 Rewine Pharmaceutical Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Rewine Pharmaceutical Main Business Overview
13.13.5 Rewine Pharmaceutical Latest Developments
13.14 Abbott Laboratories
13.14.1 Abbott Laboratories Company Information
13.14.2 Abbott Laboratories Inhalational Anesthetic Product Portfolios and Specifications
13.14.3 Abbott Laboratories Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Abbott Laboratories Main Business Overview
13.14.5 Abbott Laboratories Latest Developments
13.15 Maruishi Pharmaceutical
13.15.1 Maruishi Pharmaceutical Company Information
13.15.2 Maruishi Pharmaceutical Inhalational Anesthetic Product Portfolios and Specifications
13.15.3 Maruishi Pharmaceutical Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Maruishi Pharmaceutical Main Business Overview
13.15.5 Maruishi Pharmaceutical Latest Developments
13.16 Collins
13.16.1 Collins Company Information
13.16.2 Collins Inhalational Anesthetic Product Portfolios and Specifications
13.16.3 Collins Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Collins Main Business Overview
13.16.5 Collins Latest Developments
13.17 Mylan Seiyaku
13.17.1 Mylan Seiyaku Company Information
13.17.2 Mylan Seiyaku Inhalational Anesthetic Product Portfolios and Specifications
13.17.3 Mylan Seiyaku Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Mylan Seiyaku Main Business Overview
13.17.5 Mylan Seiyaku Latest Developments
13.18 Baxter
13.18.1 Baxter Company Information
13.18.2 Baxter Inhalational Anesthetic Product Portfolios and Specifications
13.18.3 Baxter Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Baxter Main Business Overview
13.18.5 Baxter Latest Developments
13.19 BOC Healthcare
13.19.1 BOC Healthcare Company Information
13.19.2 BOC Healthcare Inhalational Anesthetic Product Portfolios and Specifications
13.19.3 BOC Healthcare Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 BOC Healthcare Main Business Overview
13.19.5 BOC Healthcare Latest Developments
13.20 Hikma
13.20.1 Hikma Company Information
13.20.2 Hikma Inhalational Anesthetic Product Portfolios and Specifications
13.20.3 Hikma Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Hikma Main Business Overview
13.20.5 Hikma Latest Developments
13.21 Indofine Chemical Company
13.21.1 Indofine Chemical Company Company Information
13.21.2 Indofine Chemical Company Inhalational Anesthetic Product Portfolios and Specifications
13.21.3 Indofine Chemical Company Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Indofine Chemical Company Main Business Overview
13.21.5 Indofine Chemical Company Latest Developments
13.22 Medicon Lifesciences
13.22.1 Medicon Lifesciences Company Information
13.22.2 Medicon Lifesciences Inhalational Anesthetic Product Portfolios and Specifications
13.22.3 Medicon Lifesciences Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Medicon Lifesciences Main Business Overview
13.22.5 Medicon Lifesciences Latest Developments
13.23 Shandong Keyuan Pharmaceutical
13.23.1 Shandong Keyuan Pharmaceutical Company Information
13.23.2 Shandong Keyuan Pharmaceutical Inhalational Anesthetic Product Portfolios and Specifications
13.23.3 Shandong Keyuan Pharmaceutical Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Shandong Keyuan Pharmaceutical Main Business Overview
13.23.5 Shandong Keyuan Pharmaceutical Latest Developments
13.24 Lunan Pharmaceutical Group
13.24.1 Lunan Pharmaceutical Group Company Information
13.24.2 Lunan Pharmaceutical Group Inhalational Anesthetic Product Portfolios and Specifications
13.24.3 Lunan Pharmaceutical Group Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Lunan Pharmaceutical Group Main Business Overview
13.24.5 Lunan Pharmaceutical Group Latest Developments
13.25 Jiangsu Hengrui Medicine
13.25.1 Jiangsu Hengrui Medicine Company Information
13.25.2 Jiangsu Hengrui Medicine Inhalational Anesthetic Product Portfolios and Specifications
13.25.3 Jiangsu Hengrui Medicine Inhalational Anesthetic Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 Jiangsu Hengrui Medicine Main Business Overview
13.25.5 Jiangsu Hengrui Medicine Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Inhalational Anesthetic Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Inhalational Anesthetic Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Volatile Anesthetic Agents Table 4. Major Players of Nitrous Oxide Table 5. Major Players of Halothane Table 6. Major Players of Others Table 7. Global Inhalational Anesthetic Sales by Type (2018-2023) & (K Units) Table 8. Global Inhalational Anesthetic Sales Market Share by Type (2018-2023) Table 9. Global Inhalational Anesthetic Revenue by Type (2018-2023) & ($ million) Table 10. Global Inhalational Anesthetic Revenue Market Share by Type (2018-2023) Table 11. Global Inhalational Anesthetic Sale Price by Type (2018-2023) & (US$/Unit) Table 12. Global Inhalational Anesthetic Sales by Application (2018-2023) & (K Units) Table 13. Global Inhalational Anesthetic Sales Market Share by Application (2018-2023) Table 14. Global Inhalational Anesthetic Revenue by Application (2018-2023) Table 15. Global Inhalational Anesthetic Revenue Market Share by Application (2018-2023) Table 16. Global Inhalational Anesthetic Sale Price by Application (2018-2023) & (US$/Unit) Table 17. Global Inhalational Anesthetic Sales by Company (2018-2023) & (K Units) Table 18. Global Inhalational Anesthetic Sales Market Share by Company (2018-2023) Table 19. Global Inhalational Anesthetic Revenue by Company (2018-2023) ($ Millions) Table 20. Global Inhalational Anesthetic Revenue Market Share by Company (2018-2023) Table 21. Global Inhalational Anesthetic Sale Price by Company (2018-2023) & (US$/Unit) Table 22. Key Manufacturers Inhalational Anesthetic Producing Area Distribution and Sales Area Table 23. Players Inhalational Anesthetic Products Offered Table 24. Inhalational Anesthetic Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 25. New Products and Potential Entrants Table 26. Mergers & Acquisitions, Expansion Table 27. Global Inhalational Anesthetic Sales by Geographic Region (2018-2023) & (K Units) Table 28. Global Inhalational Anesthetic Sales Market Share Geographic Region (2018-2023) Table 29. Global Inhalational Anesthetic Revenue by Geographic Region (2018-2023) & ($ millions) Table 30. Global Inhalational Anesthetic Revenue Market Share by Geographic Region (2018-2023) Table 31. Global Inhalational Anesthetic Sales by Country/Region (2018-2023) & (K Units) Table 32. Global Inhalational Anesthetic Sales Market Share by Country/Region (2018-2023) Table 33. Global Inhalational Anesthetic Revenue by Country/Region (2018-2023) & ($ millions) Table 34. Global Inhalational Anesthetic Revenue Market Share by Country/Region (2018-2023) Table 35. Americas Inhalational Anesthetic Sales by Country (2018-2023) & (K Units) Table 36. Americas Inhalational Anesthetic Sales Market Share by Country (2018-2023) Table 37. Americas Inhalational Anesthetic Revenue by Country (2018-2023) & ($ Millions) Table 38. Americas Inhalational Anesthetic Revenue Market Share by Country (2018-2023) Table 39. Americas Inhalational Anesthetic Sales by Type (2018-2023) & (K Units) Table 40. Americas Inhalational Anesthetic Sales by Application (2018-2023) & (K Units) Table 41. APAC Inhalational Anesthetic Sales by Region (2018-2023) & (K Units) Table 42. APAC Inhalational Anesthetic Sales Market Share by Region (2018-2023) Table 43. APAC Inhalational Anesthetic Revenue by Region (2018-2023) & ($ Millions) Table 44. APAC Inhalational Anesthetic Revenue Market Share by Region (2018-2023) Table 45. APAC Inhalational Anesthetic Sales by Type (2018-2023) & (K Units) Table 46. APAC Inhalational Anesthetic Sales by Application (2018-2023) & (K Units) Table 47. Europe Inhalational Anesthetic Sales by Country (2018-2023) & (K Units) Table 48. Europe Inhalational Anesthetic Sales Market Share by Country (2018-2023) Table 49. Europe Inhalational Anesthetic Revenue by Country (2018-2023) & ($ Millions) Table 50. Europe Inhalational Anesthetic Revenue Market Share by Country (2018-2023) Table 51. Europe Inhalational Anesthetic Sales by Type (2018-2023) & (K Units) Table 52. Europe Inhalational Anesthetic Sales by Application (2018-2023) & (K Units) Table 53. Middle East & Africa Inhalational Anesthetic Sales by Country (2018-2023) & (K Units) Table 54. Middle East & Africa Inhalational Anesthetic Sales Market Share by Country (2018-2023) Table 55. Middle East & Africa Inhalational Anesthetic Revenue by Country (2018-2023) & ($ Millions) Table 56. Middle East & Africa Inhalational Anesthetic Revenue Market Share by Country (2018-2023) Table 57. Middle East & Africa Inhalational Anesthetic Sales by Type (2018-2023) & (K Units) Table 58. Middle East & Africa Inhalational Anesthetic Sales by Application (2018-2023) & (K Units) Table 59. Key Market Drivers & Growth Opportunities of Inhalational Anesthetic Table 60. Key Market Challenges & Risks of Inhalational Anesthetic Table 61. Key Industry Trends of Inhalational Anesthetic Table 62. Inhalational Anesthetic Raw Material Table 63. Key Suppliers of Raw Materials Table 64. Inhalational Anesthetic Distributors List Table 65. Inhalational Anesthetic Customer List Table 66. Global Inhalational Anesthetic Sales Forecast by Region (2024-2029) & (K Units) Table 67. Global Inhalational Anesthetic Revenue Forecast by Region (2024-2029) & ($ millions) Table 68. Americas Inhalational Anesthetic Sales Forecast by Country (2024-2029) & (K Units) Table 69. Americas Inhalational Anesthetic Revenue Forecast by Country (2024-2029) & ($ millions) Table 70. APAC Inhalational Anesthetic Sales Forecast by Region (2024-2029) & (K Units) Table 71. APAC Inhalational Anesthetic Revenue Forecast by Region (2024-2029) & ($ millions) Table 72. Europe Inhalational Anesthetic Sales Forecast by Country (2024-2029) & (K Units) Table 73. Europe Inhalational Anesthetic Revenue Forecast by Country (2024-2029) & ($ millions) Table 74. Middle East & Africa Inhalational Anesthetic Sales Forecast by Country (2024-2029) & (K Units) Table 75. Middle East & Africa Inhalational Anesthetic Revenue Forecast by Country (2024-2029) & ($ millions) Table 76. Global Inhalational Anesthetic Sales Forecast by Type (2024-2029) & (K Units) Table 77. Global Inhalational Anesthetic Revenue Forecast by Type (2024-2029) & ($ Millions) Table 78. Global Inhalational Anesthetic Sales Forecast by Application (2024-2029) & (K Units) Table 79. Global Inhalational Anesthetic Revenue Forecast by Application (2024-2029) & ($ Millions) Table 80. Linde Healthcare Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 81. Linde Healthcare Inhalational Anesthetic Product Portfolios and Specifications Table 82. Linde Healthcare Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 83. Linde Healthcare Main Business Table 84. Linde Healthcare Latest Developments Table 85. Air Products Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 86. Air Products Inhalational Anesthetic Product Portfolios and Specifications Table 87. Air Products Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 88. Air Products Main Business Table 89. Air Products Latest Developments Table 90. Taiyo Nippon Sanso Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 91. Taiyo Nippon Sanso Inhalational Anesthetic Product Portfolios and Specifications Table 92. Taiyo Nippon Sanso Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 93. Taiyo Nippon Sanso Main Business Table 94. Taiyo Nippon Sanso Latest Developments Table 95. Messer Group Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 96. Messer Group Inhalational Anesthetic Product Portfolios and Specifications Table 97. Messer Group Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 98. Messer Group Main Business Table 99. Messer Group Latest Developments Table 100. SOL Group Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 101. SOL Group Inhalational Anesthetic Product Portfolios and Specifications Table 102. SOL Group Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 103. SOL Group Main Business Table 104. SOL Group Latest Developments Table 105. Pfizer Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 106. Pfizer Inhalational Anesthetic Product Portfolios and Specifications Table 107. Pfizer Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 108. Pfizer Main Business Table 109. Pfizer Latest Developments Table 110. Norco Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 111. Norco Inhalational Anesthetic Product Portfolios and Specifications Table 112. Norco Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 113. Norco Main Business Table 114. Norco Latest Developments Table 115. Piramal Group Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 116. Piramal Group Inhalational Anesthetic Product Portfolios and Specifications Table 117. Piramal Group Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 118. Piramal Group Main Business Table 119. Piramal Group Latest Developments Table 120. Halocarbon Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 121. Halocarbon Inhalational Anesthetic Product Portfolios and Specifications Table 122. Halocarbon Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 123. Halocarbon Main Business Table 124. Halocarbon Latest Developments Table 125. Dideu Group Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 126. Dideu Group Inhalational Anesthetic Product Portfolios and Specifications Table 127. Dideu Group Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 128. Dideu Group Main Business Table 129. Dideu Group Latest Developments Table 130. Innopharmchem Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 131. Innopharmchem Inhalational Anesthetic Product Portfolios and Specifications Table 132. Innopharmchem Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 133. Innopharmchem Main Business Table 134. Innopharmchem Latest Developments Table 135. Aesica(Consort Medical Group) Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 136. Aesica(Consort Medical Group) Inhalational Anesthetic Product Portfolios and Specifications Table 137. Aesica(Consort Medical Group) Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 138. Aesica(Consort Medical Group) Main Business Table 139. Aesica(Consort Medical Group) Latest Developments Table 140. Rewine Pharmaceutical Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 141. Rewine Pharmaceutical Inhalational Anesthetic Product Portfolios and Specifications Table 142. Rewine Pharmaceutical Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 143. Rewine Pharmaceutical Main Business Table 144. Rewine Pharmaceutical Latest Developments Table 145. Abbott Laboratories Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 146. Abbott Laboratories Inhalational Anesthetic Product Portfolios and Specifications Table 147. Abbott Laboratories Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 148. Abbott Laboratories Main Business Table 149. Abbott Laboratories Latest Developments Table 150. Maruishi Pharmaceutical Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 151. Maruishi Pharmaceutical Inhalational Anesthetic Product Portfolios and Specifications Table 152. Maruishi Pharmaceutical Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 153. Maruishi Pharmaceutical Main Business Table 154. Maruishi Pharmaceutical Latest Developments Table 155. Collins Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 156. Collins Inhalational Anesthetic Product Portfolios and Specifications Table 157. Collins Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 158. Collins Main Business Table 159. Collins Latest Developments Table 160. Mylan Seiyaku Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 161. Mylan Seiyaku Inhalational Anesthetic Product Portfolios and Specifications Table 162. Mylan Seiyaku Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 163. Mylan Seiyaku Main Business Table 164. Mylan Seiyaku Latest Developments Table 165. Baxter Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 166. Baxter Inhalational Anesthetic Product Portfolios and Specifications Table 167. Baxter Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 168. Baxter Main Business Table 169. Baxter Latest Developments Table 170. BOC Healthcare Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 171. BOC Healthcare Inhalational Anesthetic Product Portfolios and Specifications Table 172. BOC Healthcare Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 173. BOC Healthcare Main Business Table 174. BOC Healthcare Latest Developments Table 175. Hikma Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 176. Hikma Inhalational Anesthetic Product Portfolios and Specifications Table 177. Hikma Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 178. Hikma Main Business Table 179. Hikma Latest Developments Table 180. Indofine Chemical Company Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 181. Indofine Chemical Company Inhalational Anesthetic Product Portfolios and Specifications Table 182. Indofine Chemical Company Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 183. Indofine Chemical Company Main Business Table 184. Indofine Chemical Company Latest Developments Table 185. Medicon Lifesciences Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 186. Medicon Lifesciences Inhalational Anesthetic Product Portfolios and Specifications Table 187. Medicon Lifesciences Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 188. Medicon Lifesciences Main Business Table 189. Medicon Lifesciences Latest Developments Table 190. Shandong Keyuan Pharmaceutical Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 191. Shandong Keyuan Pharmaceutical Inhalational Anesthetic Product Portfolios and Specifications Table 192. Shandong Keyuan Pharmaceutical Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 193. Shandong Keyuan Pharmaceutical Main Business Table 194. Shandong Keyuan Pharmaceutical Latest Developments Table 195. Lunan Pharmaceutical Group Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 196. Lunan Pharmaceutical Group Inhalational Anesthetic Product Portfolios and Specifications Table 197. Lunan Pharmaceutical Group Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 198. Lunan Pharmaceutical Group Main Business Table 199. Lunan Pharmaceutical Group Latest Developments Table 200. Jiangsu Hengrui Medicine Basic Information, Inhalational Anesthetic Manufacturing Base, Sales Area and Its Competitors Table 201. Jiangsu Hengrui Medicine Inhalational Anesthetic Product Portfolios and Specifications Table 202. Jiangsu Hengrui Medicine Inhalational Anesthetic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 203. Jiangsu Hengrui Medicine Main Business Table 204. Jiangsu Hengrui Medicine Latest Developments List of Figures Figure 1. Picture of Inhalational Anesthetic Figure 2. Inhalational Anesthetic Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Inhalational Anesthetic Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Inhalational Anesthetic Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Inhalational Anesthetic Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Volatile Anesthetic Agents Figure 10. Product Picture of Nitrous Oxide Figure 11. Product Picture of Halothane Figure 12. Product Picture of Others Figure 13. Global Inhalational Anesthetic Sales Market Share by Type in 2022 Figure 14. Global Inhalational Anesthetic Revenue Market Share by Type (2018-2023) Figure 15. Inhalational Anesthetic Consumed in Hospital Figure 16. Global Inhalational Anesthetic Market: Hospital (2018-2023) & (K Units) Figure 17. Inhalational Anesthetic Consumed in Clinic Figure 18. Global Inhalational Anesthetic Market: Clinic (2018-2023) & (K Units) Figure 19. Inhalational Anesthetic Consumed in Others Figure 20. Global Inhalational Anesthetic Market: Others (2018-2023) & (K Units) Figure 21. Global Inhalational Anesthetic Sales Market Share by Application (2022) Figure 22. Global Inhalational Anesthetic Revenue Market Share by Application in 2022 Figure 23. Inhalational Anesthetic Sales Market by Company in 2022 (K Units) Figure 24. Global Inhalational Anesthetic Sales Market Share by Company in 2022 Figure 25. Inhalational Anesthetic Revenue Market by Company in 2022 ($ Million) Figure 26. Global Inhalational Anesthetic Revenue Market Share by Company in 2022 Figure 27. Global Inhalational Anesthetic Sales Market Share by Geographic Region (2018-2023) Figure 28. Global Inhalational Anesthetic Revenue Market Share by Geographic Region in 2022 Figure 29. Americas Inhalational Anesthetic Sales 2018-2023 (K Units) Figure 30. Americas Inhalational Anesthetic Revenue 2018-2023 ($ Millions) Figure 31. APAC Inhalational Anesthetic Sales 2018-2023 (K Units) Figure 32. APAC Inhalational Anesthetic Revenue 2018-2023 ($ Millions) Figure 33. Europe Inhalational Anesthetic Sales 2018-2023 (K Units) Figure 34. Europe Inhalational Anesthetic Revenue 2018-2023 ($ Millions) Figure 35. Middle East & Africa Inhalational Anesthetic Sales 2018-2023 (K Units) Figure 36. Middle East & Africa Inhalational Anesthetic Revenue 2018-2023 ($ Millions) Figure 37. Americas Inhalational Anesthetic Sales Market Share by Country in 2022 Figure 38. Americas Inhalational Anesthetic Revenue Market Share by Country in 2022 Figure 39. Americas Inhalational Anesthetic Sales Market Share by Type (2018-2023) Figure 40. Americas Inhalational Anesthetic Sales Market Share by Application (2018-2023) Figure 41. United States Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 42. Canada Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 43. Mexico Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 44. Brazil Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 45. APAC Inhalational Anesthetic Sales Market Share by Region in 2022 Figure 46. APAC Inhalational Anesthetic Revenue Market Share by Regions in 2022 Figure 47. APAC Inhalational Anesthetic Sales Market Share by Type (2018-2023) Figure 48. APAC Inhalational Anesthetic Sales Market Share by Application (2018-2023) Figure 49. China Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 50. Japan Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 51. South Korea Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 52. Southeast Asia Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 53. India Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 54. Australia Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 55. China Taiwan Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 56. Europe Inhalational Anesthetic Sales Market Share by Country in 2022 Figure 57. Europe Inhalational Anesthetic Revenue Market Share by Country in 2022 Figure 58. Europe Inhalational Anesthetic Sales Market Share by Type (2018-2023) Figure 59. Europe Inhalational Anesthetic Sales Market Share by Application (2018-2023) Figure 60. Germany Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 61. France Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 62. UK Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 63. Italy Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 64. Russia Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 65. Middle East & Africa Inhalational Anesthetic Sales Market Share by Country in 2022 Figure 66. Middle East & Africa Inhalational Anesthetic Revenue Market Share by Country in 2022 Figure 67. Middle East & Africa Inhalational Anesthetic Sales Market Share by Type (2018-2023) Figure 68. Middle East & Africa Inhalational Anesthetic Sales Market Share by Application (2018-2023) Figure 69. Egypt Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 70. South Africa Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 71. Israel Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 72. Turkey Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 73. GCC Country Inhalational Anesthetic Revenue Growth 2018-2023 ($ Millions) Figure 74. Manufacturing Cost Structure Analysis of Inhalational Anesthetic in 2022 Figure 75. Manufacturing Process Analysis of Inhalational Anesthetic Figure 76. Industry Chain Structure of Inhalational Anesthetic Figure 77. Channels of Distribution Figure 78. Global Inhalational Anesthetic Sales Market Forecast by Region (2024-2029) Figure 79. Global Inhalational Anesthetic Revenue Market Share Forecast by Region (2024-2029) Figure 80. Global Inhalational Anesthetic Sales Market Share Forecast by Type (2024-2029) Figure 81. Global Inhalational Anesthetic Revenue Market Share Forecast by Type (2024-2029) Figure 82. Global Inhalational Anesthetic Sales Market Share Forecast by Application (2024-2029) Figure 83. Global Inhalational Anesthetic Revenue Market Share Forecast by Application (2024-2029)
